The UW Cardiovascular Research Center Training Program in Translational Cardiovascular Science is funded under the National Institutes of Health (NIH) through the National Research Service Award (NRSA) Training Grant (T32) mechanism, National Heart Lung and Blood Institute, as a training program in cardiovascular science for both predocotral and postdoctoral students. Its official identification is T32 HL007936. The federally-funded training program began at the University of Wisconsin-Madison in the fall of 2001.
Translational research or medicine, or more colloquially, “from cell to bedside,” means the development and application of research results from the level of the cell and molecule, through intact tissue models and animal models, to the patient or bedside. Translational research is based upon the idea that understanding mechanisms of disease at the molecular and cellular level will lead to improved therapy for patients.
At the University of Wisconsin’s UW Cardiovascular Research Center Training Program in Translational Cardiovascular Science, we believe that it is advantageous to train individuals with interests and skills that span the range from cell to bedside. This is particularly true for cardiovascular disease because it is the major cause of death in the United States.
The mission of this program is to attract individuals to careers that include cardiovascular research and to train them in research that is motivated and informed by clinical practice. In order to achieve this, the program offers predoctoral and postdoctoral (both MD and PhD) trainees an opportunity to focus research training on translational cardiovascular science, and share in a variety of activities with colleagues which foster an awareness of cardiovascular research training opportunities and challenges.
The program recognizes that training physician-scientists requires interactions with PhD researchers having complementary and related interests. The predoctoral and postdoctoral PhD trainees in this program are trained side-by-side with MD trainees in an environment that fosters and facilitates these interactions and emphasizes translational cardiovascular research and medicine.